Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer’s Disease
Biomolecules · 03.06.2025 · 15 (6) · 806
DOI: 10.3390/biom15060806 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 03.06.2025. Verfasst von Ruomin Xin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, La Jolla, San Diego, CA 92093, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, RNA, Long Noncoding, RNA, Small Nucleolar, RNA, Small Interfering. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of California, San Diego, University of California Academic Senate San Diego Division.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a leading cause of dementia worldwide. As current diagnostic approaches remain limited in sensitivity and accessibility, there is a critical need for novel, non-invasive biomarkers aiding early detection. Non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNAs), PIWI-interacting RNAs (piRNAs), and small nucleolar RNAs (snoRNAs), have emerged as promising candidates due to their regulatory roles in gene expression and association with diseases. In this study, we systematically profiled ncRNA expression from RNA sequencing data of 48 AD and 22 control blood tissue samples, aiming to evaluate their utility as biomarkers for AD classification. Differential expression analysis revealed widespread dysregulation of lncRNAs and piRNAs, with over 5000 lncRNAs and nearly 1000 piRNAs significantly upregulated in AD. Weighted gene co-expression network analysis (WGCNA) identified multiple ncRNA modules associated with the AD phenotype. Using supervised machine learning approaches, we evaluated the diagnostic potential of ncRNA expression profiles, including single-gene, multi-gene, and module-level models. Random Forest models trained on individual genes identified 121 ncRNAs with AUROC > 0.8. Feature importance analysis emphasized ncRNAs such as lnc-MYEF2-3, lnc-PRKACB2, and HBII-115 as major contributors to diagnostic accuracy. These findings support the potential of ncRNA signatures as reliable and non-invasive biomarkers for AD diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, La Jolla, San Diego, CA 92093, USA.
- Research Service, VA San Diego Healthcare System, San Diego, CA 92161, USA.
- School of Medicine, University of California, San Francisco, CA 94143, USA.
- Department of Pathology, University of California, La Jolla, San Diego, CA 92093, USA.
- Pathology Service, VA San Diego Healthcare System, San Diego, CA 92161, USA.
ORCID-Profile: Wei Tse Li, Weg M Ongkeko
Förderung
- University of California, San Diego
- University of California Academic Senate San Diego Division
Zitieren
APA
Xin, R., Kim, E., Li, W. T., Wang-Rodriguez, J., & Ongkeko, W. M. (2025). Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer’s Disease. Biomolecules, 15(6), 806. https://doi.org/10.3390/biom15060806
Vancouver
Xin R, Kim E, Li WT, Wang-Rodriguez J, Ongkeko WM. Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer’s Disease. Biomolecules. 2025;15(6):806. doi:10.3390/biom15060806
BibTeX
@article{Xin2025,
author = {Xin, Ruomin and Kim, Elizabeth and Li, Wei Tse and Wang-Rodriguez, Jessica and Ongkeko, Weg M},
title = {Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer’s Disease},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {6},
pages = {806},
doi = {10.3390/biom15060806}
}
EUVIMED